Home Cart 0 Sign in  
X

[ CAS No. 89711-08-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 89711-08-0
Chemical Structure| 89711-08-0
Chemical Structure| 89711-08-0
Structure of 89711-08-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 89711-08-0 ]

Related Doc. of [ 89711-08-0 ]

Alternatived Products of [ 89711-08-0 ]

Product Details of [ 89711-08-0 ]

CAS No. :89711-08-0 MDL No. :MFCD01321273
Formula : C7H13NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :ACNRTYKOPZDRCO-UHFFFAOYSA-N
M.W : 159.18 Pubchem ID :4247255
Synonyms :

Calculated chemistry of [ 89711-08-0 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.71
Num. rotatable bonds : 5
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 40.48
TPSA : 55.4 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.94 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.62
Log Po/w (XLOGP3) : 0.46
Log Po/w (WLOGP) : 0.71
Log Po/w (MLOGP) : 0.19
Log Po/w (SILICOS-IT) : 0.28
Consensus Log Po/w : 0.65

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.79
Solubility : 26.0 mg/ml ; 0.163 mol/l
Class : Very soluble
Log S (Ali) : -1.19
Solubility : 10.2 mg/ml ; 0.0643 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.17
Solubility : 10.7 mg/ml ; 0.0671 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.77

Safety of [ 89711-08-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 89711-08-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 89711-08-0 ]
  • Downstream synthetic route of [ 89711-08-0 ]

[ 89711-08-0 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 121505-93-9 ]
  • [ 89711-08-0 ]
YieldReaction ConditionsOperation in experiment
89%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran; diethyl ether at 0℃; for 0.5 h;
Stage #2: With potassium hydrogensulfate; water In tetrahydrofuran; diethyl ether for 0.166667 h;
Boc-Gly-N-methoxy-N-methylaride (19) (4.37 g, 20 mmole) in 150 ml of anhydrous THF was stirred in a ice-water bath under argon for 30 min. A solution of LAH in diethyl ether (1 M) (30 ml, 30 mmole) was added to the above well stirred solution by cannula under argon. The resulting solution was stirred for 30 min. A solution of potassium hydrogensulfate (4.77 g, 35 mmole) in 60 ml of water was gradually added to the reaction solution and stirred for 10 min. Organic solvents in the reaction mixture were evaporated under reduced pressure. An additional 60 ml of water was added to the aqueous residue, which was then extracted with DCM (100 ml.x.4). The combined DCM extracts were washed with 1 M hydrochloric acid solution (100 ml.x.4), saturated sodium bicarbonate solution (100 ml.x.2), and saturated sodium chloride solution (100 ml), dried with 4 g of magnesium sulfate overnight, and filtered. Evaporation of the solvent under reduced pressure left a yellowish oil 20 (2.83 g) which was used without further purification. Yield: 89percent. TLC Rf=0.44 (hexane-EtOAc=1:1). 1H-NMR (90 MHz, CDCl3) δ ppm: 9.60 (s, 1 H), 5.26 (s, br, 1 H), 4.04 (d, 2 H, J=5.1 Hz), and 1.46 (s, 9 H).
50% With lithium aluminium tetrahydride In tetrahydrofuran at -78℃; for 0.166667 h; Inert atmosphere Boc-Gly-N(Me)-OMe (1, 5.00 mmol) was dissolved in THF (10mL) and injected through a septum to a suspension of LiAlH4 (6.25 mmol) inTHF (10 mL) at 78 °C under argon atmosphere. TLC control after 10 min usingCH2Cl2/EtOAc (8.5+1.5) indicated the completion of the reaction. Subsequently,the reaction mixture was quenched with 10percent KHSO4 (1 20 mL) and extractedwith diethyl ether (30 mL). The organic layer was washed with 10percent KHSO4 (1 20 mL) and sat. NaHCO3 (2 x 20 mL), dried over Na2SO4 and evaporatedyielding 2 as a colorless resin (50percent). 1H NMR (500 MHz, DMSO-d6) d 1.38 (s,9H), 3.72 (d, 3J = 5.7 Hz, 2H), 7.16 (br t, 1H), 9.44 (s, 1H). 13C NMR (125 MHz,DMSO-d6) d 28.26, 50.48, 78.46, 156.09, 200.74.
9.6 g With lithium aluminium tetrahydride In tetrahydrofuran for 1 h; Cooling with ice To an ice cooled suspension of 653 LiAlH4 (2.13g, 56mmol) in dry THF (20ml) was added F1 (12.2g, 56mmol) in small batches to avoid drastic reaction. After the addition, the mixture was stirred for a further 1h. Then the reaction was quenched cautiously by addition of saturated Na2CO3 solution dropwise until no gas bubbles were generated, followed by addition of water dropwise with vigorous stirring. The solid so formed was filtered off under reduced pressure and washed with THF. The filtrate was concentrated to afford F2 (9.6g) as a jelly which could be used in next step without further purification.
9.6 g With lithium aluminium tetrahydride In tetrahydrofuran for 1 h; To an ice cooled suspension of LiA1H4 (2.13 g, 56 mmol) in dry THF (20 ml) was added Fl (12.2 g, 56 mmol) in small batches to avoid drastic reaction. After the addition, the mixture was stirred for a further 1 h. Then the reaction was quenched cautiously by addition of saturated Na2CO3 solution dropwise until no gas bubbles were generated, followed by addition of water dropwise with vigorous stirring. The solid so formed was filtered off under reduced pressure and washed with THF. The filtrate was concentrated to afford F2 (9.6 g) as a jelly which could be used in next step without thrther purification.

Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2001, vol. 20, # 4-7, p. 1393 - 1397
[2] Patent: US2006/161007, 2006, A1, . Location in patent: Page/Page column 3; 8-9; Sheet 1
[3] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 1, p. 65 - 77
[4] Tetrahedron, 2001, vol. 57, # 23, p. 4903 - 4923
[5] European Journal of Medicinal Chemistry, 1991, vol. 26, # 9, p. 921 - 928
[6] Tetrahedron, 2002, vol. 58, # 9, p. 1719 - 1737
[7] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 11, p. 2008 - 2012
[8] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 10, p. 1501 - 1510
[9] Journal of Medicinal Chemistry, 1994, vol. 37, # 20, p. 3383 - 3388
[10] Tetrahedron Letters, 1999, vol. 40, # 45, p. 7925 - 7928
[11] Organic Letters, 2004, vol. 6, # 25, p. 4699 - 4702
[12] Journal of the American Chemical Society, 2006, vol. 128, # 51, p. 16456 - 16457
[13] Tetrahedron, 2006, vol. 62, # 8, p. 1787 - 1798
[14] Journal of Medicinal Chemistry, 2002, vol. 45, # 8, p. 1624 - 1632
[15] Journal of Medicinal Chemistry, 2007, vol. 50, # 23, p. 5790 - 5806
[16] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 22, p. 8119 - 8133
[17] Journal of Organic Chemistry, 2014, vol. 79, # 3, p. 1254 - 1264
[18] Patent: EP2725024, 2014, A1, . Location in patent: Paragraph 0553
[19] Patent: US2014/171431, 2014, A1, . Location in patent: Paragraph 0916
[20] Patent: WO2017/21730, 2017, A1, . Location in patent: Page/Page column 54; 55
[21] Organic Letters, 2018, vol. 20, # 13, p. 3883 - 3887
  • 2
  • [ 26690-80-2 ]
  • [ 89711-08-0 ]
YieldReaction ConditionsOperation in experiment
69% With 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione In dimethyl sulfoxide at 20℃; Inert atmosphere A round-bottom flask was charged with 48 (0.80 g, 10.0 mmol)and IBX36 (2.80 g, 10.0 mmol) under argon atmosphere. DMSO(25 mL) was added to the mixture and then stirring was continued overnight at rt. The reaction mixture was quenched with water(200 mL) and filtered under reduced pressure. The filtrate was extracted with ethyl acetate. The organic layer was dried (Na2SO4)and concentrated under reduced pressure. Purification of the crude residue by SiO2 column chromatography (CHCl3:EtOAc = 7:3) gave49 (69percent; lit. 55percent37) as an oil; 1H NMR (500 MHz, CDCl3): d 9.65 (2H,br s, HCO), 5.16 (1H, br, NH), 4.06 (2H, s, CH2), 1.45 (9H, s, C(CH3)3).
66% With sulfur trioxide pyridine complex In dimethyl sulfoxide at 20℃; Ice cooling Reference Example 1 tert-Butyl (2-oxoethyl) carbamateTo a mixed solution of tert-butyl (2- hydroxyethyl) carbamate (10.0 g) in dimethyl sulfoxide (50 mL) and triethylamine (12.3 g) was added sulfur trioxide pyridine complex (15.0 g) under ice-cooling, and the mixture was stirred for 1 hr. The reaction mixture was further stirred at room temperature for 3 hr, 1 mol/L hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The separated aqueous layer was extracted again with ethyl acetate. The combined organic layers were washed with saturated brine, dried over magnesium sulfate and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent :hexane-ethyl acetate=17 : 3-->13 : 7) to give the title compound as a pale-yellow oil (yield 6.50 g, 66percent). 1H-NMR (CDCl3) δ:l.46 ( 9H, s) , 4.08 (2H, d, J=4.5Hz) , 5.19 (lH,brs) , 9.66(lH,s) .
14% With oxalyl dichloride; dimethyl sulfoxide; triethylamine In dichloromethane at -78 - 20℃; for 1 h; Oxalyl chloride (1.3 mL, 15 mmol) was added to a reaction chamber containing methylene chloride (120 mL) at -78° C. and a solution of dimethyl sulfoxide (2.45 mL, 30 mmol) dissolved in methylene chloride (20 mL) was added. The resulting solution was stirred for 10 minutes at -78° C. A solution of N-Boc-ethanolamine (2 g, 12.4 mmol) dissolved in methylene chloride (20 mL) was slowly added and then triethylamine (8.64 ml, 62 mmol) was added. The resulting solution was stirred for 30 minutes at -78° C. and additional 30 minutes at room temperature, washed with water (100 mL) and saline (100 mL). The organic layer was dehydrated with anhydrous sodium sulfate, concentrated under reduced pressure, and applied to column chromatography (n-hex:EA=3:11:1) to yield Compound I (270 mg (14percent)).1H NMR (600 MHz, DMSO-d6) δ=7.83 (s, 1H), 7.49 (s, 1H), 6.88 (d, J=5.4 Hz, 1H), 6.36 (br, 2H), 4.81 (br, 1H), 3.13 (m, 4H), 1.39 (s, 9H)
14% With oxalyl dichloride; dimethyl sulfoxide; triethylamine In dichloromethane at -78 - 20℃; for 1.16667 h; Oxalyl chloride (1.3 mL, 15 mmol) was added to a reaction chamber containing methylene chloride (120 mL) at -78°C and a solution of dimethyl sulfoxide (2.45 mL, 30 mmol) dissolved in methylene chloride (20 mL) was added. The resulting solution was stirred for 10 minutes at -78°C. A solution of N-Boc-ethanolamine (2g, 12.4 mmol) dissolved in methylene chloride (20 mL) was slowly added and then triethylamine (8.64 ml, 62 mmol) was added. The resulting solution was stirred for 30 minutes at -78°C and additional 30 minutes at room temperature, washed with water (100 mL) and saline (100 mL). The organic layer was dehydrated with anhydrous sodium sulfate, concentrated under reduced pressure, and applied to column chromatography (n-hex : EA = 3 :1∼1:1) to yield Compound I (270 mg (14percent)). 1H NMR (600MHz, DMSO-d6) δ= 7.83(s, 1H), 7.49(s, 1H), 6.88(d, J = 5.4Hz, 1H), 6.36(br, 2H), 4.81(br, 1H), 3.13(m, 4H), 1.39(s, 9H)
80% With triethylamine In dichloromethane; dimethyl sulfoxide Step B:
2-(t-Butoxycarbonylamino)acetaldehyde
To a solution of 700 mg (4.34 mmol) of 2-(t-butoxycarbonylamino)ethanol in 35 mL of dry methylene chloride was added 4.0 mL of dimethylsulfoxide and 4.8 mL (35 mmol) of triethylamine, followed by 2.8 g (17 mmol) of pyridine sulfur trioxide complex in three portions over 5 minutes.
The reaction was stirred at room temperature for 3 hours then diluted with 500 mL of ether.
The mixture was transferred to a separatory funnel and washed with 1N HCl (2*50 mL), saturated aqueous sodium bicarbonate (100 mL), and brine (100 mL).
The organic layer was dried over magnesium sulfate, filtered, and the solvent removed under vacuum to afford 550 mg (80percent) of product which was used without further purification. 1 H NMR (200 MHz,CDCl3): 1.40 (s,9H), 4.05 (d,7 Hz,2H), 5.17 (s,1H), 9.62 (s,1H).
80% With triethylamine In dichloromethane; dimethyl sulfoxide Step C:
N-(t-Butoxycarbonyl)glycinal
To a solution of 700 mg (4.34 mmol) of 2-(t-butoxycarbonylamino)ethanol in 35 mL of dry methylene chloride was added 4.8 mL (35 mmol) of triethylamine and 4.0 mL of dry dimethylsulfoxide.
To the resulting solution was added in portions 2.8 g (17 mmol) of pyridine-sulfur trioxide complex.
The resulting brown solution was s stirred at room temperature for 3 hours.
The mixture was diluted with 500 mL of ether and transferred to a separatory funnel.
The mixture was washed with 1N aqueous hydrochloric acid (2*50 mL), saturated aqueous sodium bicarbonate (100 mL) and brine (100 mL).
The organic layer was removed, dried over magnesium sulfate, filtered and the solvent removed under vacuum to afford 550 mg (80percent) of the product as an oil. 1 H NMR (200 MHz, CDCl3): δ1.42 (s, 9H), 4.04 (d, 4 Hz, 2H), 5.18 (s, 1H), 9.62 (s, 1H).
2 g With Dess-Martin periodane In dichloromethane at 0 - 20℃; for 16 h; Step 2: Preparation of tert-butyl (2-oxoeth l)carbamate To a solution of tert-butyl (2-hydroxyethyl)carbamate (4 g, 24.81 mmol) in DCM (200 mL) was added Dess-Martin reagent (12.62 g, 29.77 mmol) at 0 °C. The reaction was stirred at ambient temperature for 16 h. Saturated aqueous Na2C03 (80 mL) and Na2S203 (80 mL) were added to the reaction and stirred for lh. The resulting biphasic mixture was transfered to a separatory funnel. The layers were separated and the aqueous phase was extracted with DCM (3 x 200 mL). The combined organics were dried over anhydrous Na2S04, filtered and concentrated in vacuo. The resulting oil was purified by flash column chromatography with an isocratic elution of EtOAc (10percent) and hexanes (90 percent) to provide tert-butyl (2- oxoethyl)carbamate (2 g, 12.56 mmol) as a colorless oil. LCMS [M+H]+ = 160.1.

Reference: [1] Synthesis, 2011, # 14, p. 2321 - 2333
[2] Chemical Communications, 2007, # 21, p. 2136 - 2138
[3] Journal of the American Chemical Society, 2015, vol. 137, # 32, p. 10036 - 10039
[4] Helvetica Chimica Acta, 1997, vol. 80, # 4, p. 1244 - 1259
[5] Organic and Biomolecular Chemistry, 2003, vol. 1, # 20, p. 3527 - 3534
[6] Phytochemistry (Elsevier), 1990, vol. 29, # 3, p. 701 - 703
[7] European Journal of Organic Chemistry, 2014, vol. 2014, # 24, p. 5331 - 5345
[8] Tetrahedron Letters, 1999, vol. 40, # 26, p. 4905 - 4908
[9] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 3, p. 1094 - 1112
[10] Patent: WO2010/24451, 2010, A1, . Location in patent: Page/Page column 50; 51
[11] Bioorganic and medicinal chemistry letters, 2004, vol. 14, # 1, p. 275 - 278
[12] Journal of Organic Chemistry, 2002, vol. 67, # 12, p. 4017 - 4029
[13] Chemical and pharmaceutical bulletin, 2002, vol. 50, # 2, p. 239 - 252
[14] Patent: US2012/264727, 2012, A1, . Location in patent: Page/Page column 33; 34
[15] Patent: EP2706062, 2014, A2, . Location in patent: Paragraph 0069
[16] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2487 - 2493
[17] Journal of Medicinal Chemistry, 2002, vol. 45, # 14, p. 2891 - 2893
[18] Heterocycles, 2003, vol. 60, # 4, p. 791 - 798
[19] Synthesis, 2003, # 18, p. 2805 - 2810
[20] Synlett, 2003, # 10, p. 1539 - 1541
[21] Journal of Organic Chemistry, 2005, vol. 70, # 6, p. 1963 - 1977
[22] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 6, p. 1486 - 1490
[23] Tetrahedron Letters, 2006, vol. 47, # 19, p. 3295 - 3298
[24] Patent: US5206235, 1993, A,
[25] Patent: US5438136, 1995, A,
[26] Patent: WO2005/41888, 2005, A2, . Location in patent: Page/Page column 86
[27] Patent: US7544794, 2009, B1, . Location in patent: Page/Page column 14-15
[28] Patent: WO2004/55008, 2004, A1, . Location in patent: Page 49
[29] Patent: WO2012/82436, 2012, A2, . Location in patent: Page/Page column 288
[30] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 11, p. 3140 - 3144
[31] Patent: WO2015/88565, 2015, A1, . Location in patent: Paragraph 00225
[32] RSC Advances, 2016, vol. 6, # 31, p. 25713 - 25723
[33] Patent: JP2016/190813, 2016, A, . Location in patent: Paragraph 0066-0068
[34] Patent: CN108129404, 2018, A, . Location in patent: Paragraph 0106; 0107
[35] Patent: WO2005/41888, 2005, A2, . Location in patent: Page/Page column 86
  • 3
  • [ 137618-48-5 ]
  • [ 89711-08-0 ]
YieldReaction ConditionsOperation in experiment
56% With sodium periodate In water at 20℃; for 2 h; Step 2
tert-Butyl 2-oxoethylcarbamate:
Sodium periodate (41.52 g; 194 mmol; 1.00 equiv) was added in several batches to tert-butyl 2,3-dihydroxypropylcarbamate (37 g; 194 mmol; 1.00 equiv) dissolved in water (300 mL).
The resulting solution was stirred at ambient temperature for about 2 hours.
The solids were were removed by filtration.
Standard extractive workup with dichloromethane, gave the title product as a white solid (17 g; 56percent yield).
1H NMR (300 MHz, CDCl3) δ 9.65 (s, 1H), 5.26 (s, 1H), 4.07 (d, J=4.5 Hz, 2H), 1.46 (s, 9H).
Reference: [1] Journal of Heterocyclic Chemistry, 2008, vol. 45, # 2, p. 445 - 451
[2] Journal of the American Chemical Society, 2015, vol. 137, # 39, p. 12442 - 12445
[3] Journal of the American Chemical Society, 2005, vol. 127, # 10, p. 3339 - 3345
[4] Patent: US2010/9950, 2010, A1, . Location in patent: Page/Page column 24
[5] Patent: US6750348, 2004, B1, . Location in patent: Page column 66
[6] Journal of Medicinal Chemistry, 2014, vol. 57, # 11, p. 4969 - 4974
[7] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 20, p. 4509 - 4512
[8] Patent: WO2018/175927, 2018, A2, . Location in patent: Paragraph 00303
  • 4
  • [ 31954-27-5 ]
  • [ 89711-08-0 ]
Reference: [1] Journal of Organic Chemistry, 2002, vol. 67, # 7, p. 2197 - 2205
[2] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 10, p. 2812 - 2815
[3] Chemical and Pharmaceutical Bulletin, 1992, vol. 40, # 7, p. 1937 - 1939
[4] Heterocycles, 1998, vol. 48, # 7, p. 1331 - 1335
[5] Heterocycles, 2003, vol. 60, # 4, p. 791 - 798
[6] Angewandte Chemie - International Edition, 2006, vol. 45, # 35, p. 5870 - 5874
[7] Organic Letters, 2002, vol. 4, # 17, p. 2913 - 2916
[8] Heterocycles, 2003, vol. 60, # 4, p. 791 - 798
[9] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2487 - 2493
[10] Journal of Organic Chemistry, 2008, vol. 73, # 13, p. 5180 - 5182
[11] Chemistry - A European Journal, 2009, vol. 15, # 14, p. 3457 - 3473
[12] Patent: WO2004/83173, 2004, A2, . Location in patent: Page 31
[13] Patent: EP1721905, 2006, A1, . Location in patent: Page/Page column 24
[14] Synlett, 2011, # 2, p. 211 - 214
[15] Journal of Organic Chemistry, 2012, vol. 77, # 8, p. 4005 - 4016
[16] Biochemistry, 2013, vol. 52, # 36, p. 6182 - 6196
  • 5
  • [ 78888-18-3 ]
  • [ 89711-08-0 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 15, p. 3457 - 3465
[2] Journal of Medicinal Chemistry, 1984, vol. 27, # 6, p. 711 - 712
[3] Journal of Medicinal Chemistry, 1986, vol. 29, # 1, p. 104 - 111
[4] Journal of Medicinal Chemistry, 1992, vol. 35, # 6, p. 1067 - 1075
[5] Journal of the American Chemical Society, 2010, vol. 132, # 6, p. 1748 - 1749
[6] Patent: US2002/19527, 2002, A1,
[7] Organic Letters, 2015, vol. 17, # 7, p. 1774 - 1777
[8] Angewandte Chemie - International Edition, 2014, vol. 53, # 41, p. 11075 - 11078
  • 6
  • [ 616-30-8 ]
  • [ 24424-99-5 ]
  • [ 89711-08-0 ]
Reference: [1] Patent: WO2017/136871, 2017, A1, . Location in patent: Paragraph 0186
[2] Patent: WO2018/157190, 2018, A1, . Location in patent: Paragraph 0179
  • 7
  • [ 79-37-8 ]
  • [ 26690-80-2 ]
  • [ 89711-08-0 ]
Reference: [1] Patent: US2005/165089, 2005, A1, . Location in patent: Page/Page column 35
  • 8
  • [ 24424-99-5 ]
  • [ 89711-08-0 ]
Reference: [1] Chemical Communications, 2007, # 21, p. 2136 - 2138
[2] Synthesis, 2003, # 18, p. 2805 - 2810
[3] Heterocycles, 2003, vol. 60, # 4, p. 791 - 798
[4] Heterocycles, 2003, vol. 60, # 4, p. 791 - 798
[5] Journal of Organic Chemistry, 2002, vol. 67, # 12, p. 4017 - 4029
[6] Helvetica Chimica Acta, 1997, vol. 80, # 4, p. 1244 - 1259
[7] Journal of Medicinal Chemistry, 1984, vol. 27, # 6, p. 711 - 712
[8] Journal of Organic Chemistry, 1988, vol. 53, # 15, p. 3457 - 3465
[9] Phytochemistry (Elsevier), 1990, vol. 29, # 3, p. 701 - 703
[10] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 11, p. 3140 - 3144
[11] Journal of Medicinal Chemistry, 2014, vol. 57, # 11, p. 4969 - 4974
[12] European Journal of Organic Chemistry, 2014, vol. 2014, # 24, p. 5331 - 5345
[13] Patent: WO2015/88565, 2015, A1,
[14] Angewandte Chemie - International Edition, 2014, vol. 53, # 41, p. 11075 - 11078
[15] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 20, p. 4509 - 4512
[16] Journal of the American Chemical Society, 2015, vol. 137, # 39, p. 12442 - 12445
[17] Patent: WO2018/175927, 2018, A2,
  • 9
  • [ 7790-21-8 ]
  • [ 1378293-39-0 ]
  • [ 616-30-8 ]
  • [ 24424-99-5 ]
  • [ 89711-08-0 ]
Reference: [1] Patent: US6414112, 2002, B1,
[2] Patent: US5714331, 1998, A,
[3] Patent: US5719262, 1998, A,
[4] Patent: US6710164, 2004, B1,
  • 10
  • [ 7790-21-8 ]
  • [ 24424-99-5 ]
  • [ 137618-48-5 ]
  • [ 89711-08-0 ]
YieldReaction ConditionsOperation in experiment
93% With hydrogenchloride; sodium hydroxide In water; ethyl acetate (a)
Preparation of (bocamino) acetaldehyde
3-Amino-1,2-propanediol(80.0 g; 0.88 mol) was dissolved in water (1500 ml) and the solution was cooled to 4° C., whereafter Boc anhydride (230 g; 1.05 mol) was added at once.
The solution was gently heated to room temperature with a water bath.
The pH was kept at 10.5 by the dropwise addition of sodium hydroxide.
Over the course of the reaction a total of 70.2 g NaOH, dissolved in 480 ml water, was added.
After stirring overnight, ethyl acetate (1000 ml) was added and the mixture was cooled to 0° C. and the pH was adjusted to 2.5 by the addition of 4M hydrochloric acid.
The ethyl acetate layer was removed and the acidic aqueous solution was extracted with more ethyl acetate (8*500 ml).
The combined ethyl acetate solution was reduced to a volume of 1500 ml using a rotary evaporator.
The resulting solution was washed with half saturated potassium hydrogen sulphate (1500 ml) and then with saturated sodium chloride.
It then was dried over magnesium sulphate and evaporated to dryness, in vacuo. Yield. 145.3 g (86percent)
3-Bocamino-1,2-propanediol (144.7 g; 0.757 mol) was suspended in water (750 ml) and potassium periodate (191.5 g; 0.833 mol) was added.
The mixture was stirred under nitrogen for 2.5 h and the precipitated potassium iodate was removed by filtration and washed once with water (100 ml).
The aqueous phase was extracted with chloroform (6*400 ml).
The chloroform extracts were dried and evaporated to dryness, in vacuoo Yield 102 g (93percent) of an oil.
The (bocamino)acetaldehyde was purified by kugelrohr distillation at 84° C. and 0.3 mmHg in two portions.
The yield 79 g (77percent) of a colorless oil.
93% With hydrogenchloride; sodium hydroxide In water; ethyl acetate (a)
Preparation of (bocamino)acetaldehyde
3-Amino-1,2-propanediol(80.0 g; 0.88 mol) was dissolved in water (1500 ml) and the solution was cooled to 4° C., whereafter Boc anhydride (230 g; 1.05 mol) was added at once.
The solution was gently heated to room temperature with a water bath.
The pH was kept at 10.5 by the dropwise addition of sodium hydroxide.
Over the course of the reaction a total of 70.2 g NaOH, dissolved in 480 ml water, was added.
After stirring overnight, ethyl acetate (1000 ml) was added and the mixture was cooled to 0° C. and the pH was adjusted to 2.5 by the addition of 4 M hydrochloric acid.
The ethyl acetate layer was removed and the acidic aqueous solution was extracted with more ethyl acetate (8*500 ml).
The combined ethyl acetate solution was reduced to a volume of 1500 ml using a rotary evaporator.
The resulting solution was washed with half saturated potassium hydrogen sulphate (1500 ml) and then with saturated sodium chloride.
It then was dried over magnesium sulphate and evaporated to dryness, in vacuo. Yield. 145.3 g (86percent)
3-Bocamino-1,2-propanediol (144.7 g; 0.757 mol) was suspended in water (750 ml) and potassium periodate (191.5 g; 0.833 mol) was added.
The mixture was stirred under nitrogen for 2.5 h and the precipitated potassium iodate was removed by filtration and washed once with water (100 ml).
The aqueous phase was extracted with chloroform (6*400 ml).
The chloroform extracts were dried and evaporated to dryness, in vacuo.
Yield 102 g (93percent) of an oil.
The (bocamino)acetaldehyde was purified by kugelrohr distillation at 84° C. and 0.3 mmHg in two portions.
The yield 79 g (77percent) of a colorless oil.
Reference: [1] Patent: US5539082, 1996, A,
[2] Patent: US6228982, 2001, B1,
  • 11
  • [ 4530-20-5 ]
  • [ 89711-08-0 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 10, p. 1501 - 1510
[2] European Journal of Medicinal Chemistry, 1991, vol. 26, # 9, p. 921 - 928
[3] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2487 - 2493
[4] Journal of Organic Chemistry, 2014, vol. 79, # 3, p. 1254 - 1264
[5] Patent: EP2725024, 2014, A1,
[6] Patent: US2014/171431, 2014, A1,
[7] RSC Advances, 2016, vol. 6, # 31, p. 25713 - 25723
[8] Patent: WO2017/21730, 2017, A1,
[9] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 11, p. 2008 - 2012
  • 12
  • [ 7790-21-8 ]
  • [ 616-30-8 ]
  • [ 24424-99-5 ]
  • [ 137618-48-5 ]
  • [ 89711-08-0 ]
YieldReaction ConditionsOperation in experiment
93% With hydrogenchloride; sodium hydroxide In water; ethyl acetate (a)
Preparation of (bocamino)acetaldehyde
3-Amino-1,2-propanediol (80.0 g; 0.88 mol) was dissolved in water (1500 ml) and the solution was cooled to 4° C., whereafter Boc anhydride (230 g; 1.05 mol) was added at once.
The solution was gently heated to room temperature with a water bath.
The pH was kept at 10.5 by the dropwise addition of sodium hydroxide.
Over the course of the reaction a total of 70.2 g NaOH, dissolved in 480 ml water, was added.
After stirring overnight, ethyl acetate (1000 ml) was added and the mixture was cooled to 0° C. and the pH was adjusted to 2.5 by the addition of 4 M hydrochloric acid.
The ethyl acetate layer was removed and the acidic aqueous solution was extracted with more ethyl acetate (8*500 ml).
The combined ethyl acetate solution was reduced to a volume of 1500 ml using a rotary evaporator.
The resulting solution was washed with half saturated potassium hydrogen sulphate (1500 ml) and then with saturated sodium chloride.
It then was dried over magnesium sulphate and evaporated to dryness, in vacuo. Yield. 145.3 g (86percent)
3-Bocamino-1,2-propanediol (144.7 g; 0.757 mol) was suspended in water (750 ml) and potassium periodate (191.5 g; 0.833 mol) was added.
The mixture was stirred under nitrogen for 2.5 h and the precipitated potassium iodate was removed by filtration and washed once with water (100 ml).
The aqueous phase was extracted with chloroform (6*400 ml).
The chloroform extracts were dried and evaporated to dryness, in vacuo.
Yield 102 g (93percent) of an oil.
The (bocamino)acetaldehyde was purified by kugelrohr distillation at 84° C. and 0.3 mmHg in two portions.
The yield 79 g (77percent) of a colorless oil.
Reference: [1] Patent: US6713602, 2004, B1,
  • 13
  • [ 118517-02-5 ]
  • [ 89711-08-0 ]
Reference: [1] Bioorganic and medicinal chemistry letters, 2004, vol. 14, # 1, p. 275 - 278
  • 14
  • [ 4202-14-6 ]
  • [ 89711-08-0 ]
  • [ 92136-39-5 ]
Reference: [1] Journal of Organic Chemistry, 2014, vol. 79, # 3, p. 1254 - 1264
  • 15
  • [ 89711-08-0 ]
  • [ 75-04-7 ]
  • [ 113283-93-5 ]
Reference: [1] Patent: WO2009/11775, 2009, A1, . Location in patent: Page/Page column 31
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 89711-08-0 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 82353-56-8

[ 82353-56-8 ]

(R)-tert-Butyl (1-oxopropan-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 114857-00-0

[ 114857-00-0 ]

tert-Butyl (1-oxopropan-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 38267-76-4

[ 38267-76-4 ]

tert-Butyl ethylcarbamate

Similarity: 0.92

Chemical Structure| 123387-72-4

[ 123387-72-4 ]

tert-Butyl methyl(2-oxoethyl)carbamate

Similarity: 0.90

Chemical Structure| 170384-29-9

[ 170384-29-9 ]

tert-Butyl (2-oxopropyl)carbamate

Similarity: 0.90

Aldehydes

Chemical Structure| 82353-56-8

[ 82353-56-8 ]

(R)-tert-Butyl (1-oxopropan-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 114857-00-0

[ 114857-00-0 ]

tert-Butyl (1-oxopropan-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 123387-72-4

[ 123387-72-4 ]

tert-Butyl methyl(2-oxoethyl)carbamate

Similarity: 0.90

Chemical Structure| 315718-06-0

[ 315718-06-0 ]

tert-Butyl ethyl(2-oxoethyl)carbamate

Similarity: 0.88

Chemical Structure| 109608-77-7

[ 109608-77-7 ]

tert-Butyl (2-methyl-1-oxopropan-2-yl)carbamate

Similarity: 0.88

Amides

Chemical Structure| 82353-56-8

[ 82353-56-8 ]

(R)-tert-Butyl (1-oxopropan-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 114857-00-0

[ 114857-00-0 ]

tert-Butyl (1-oxopropan-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 38267-76-4

[ 38267-76-4 ]

tert-Butyl ethylcarbamate

Similarity: 0.92

Chemical Structure| 123387-72-4

[ 123387-72-4 ]

tert-Butyl methyl(2-oxoethyl)carbamate

Similarity: 0.90

Chemical Structure| 170384-29-9

[ 170384-29-9 ]

tert-Butyl (2-oxopropyl)carbamate

Similarity: 0.90

Amines

Chemical Structure| 82353-56-8

[ 82353-56-8 ]

(R)-tert-Butyl (1-oxopropan-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 114857-00-0

[ 114857-00-0 ]

tert-Butyl (1-oxopropan-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 38267-76-4

[ 38267-76-4 ]

tert-Butyl ethylcarbamate

Similarity: 0.92

Chemical Structure| 123387-72-4

[ 123387-72-4 ]

tert-Butyl methyl(2-oxoethyl)carbamate

Similarity: 0.90

Chemical Structure| 170384-29-9

[ 170384-29-9 ]

tert-Butyl (2-oxopropyl)carbamate

Similarity: 0.90